MedPath

Diet Intervention, Head and Neck Cancer, Feasibility

Not Applicable
Completed
Conditions
Head and Neck Cancer
Interventions
Behavioral: Usual Dietary Care
Behavioral: Cruciferous and Dark Leafy Green Intervention
Registration Number
NCT03013699
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This study will examine the effects of a dietary intervention in post-treatment head and neck cancer survivors on the ability to function physically, tiredness, and quality of life, as well as on changing markers in the blood that are associated with better recurrence and survival.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria

Patients will be eligible to participate if they are 1) diagnosed with Stage I - IV oral, hypopharyngeal, nasopharyngeal, oropharyngeal, or laryngeal cancer; 2) age 19+; 3) at least 6 months - 2 years post-treatment; 4) able to consume foods orally; 5) no evidence of disease; 6) English-speaking

Read More
Exclusion Criteria

Patients will not be eligible to participate if they have 1) dementia or organic brain syndrome; 2) severe emotional distress; 3) active schizophrenia; 3) another diagnosis of cancer in the past five years (not including skin or cervical cancer in situ)

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual Dietary CareUsual Dietary CareParticipants receive standard educational materials that focus on healthy eating for cancer survivors and the opportunity to briefly discuss nutrition-related concerns with the Registered Dietitian weekly.
Cruciferous and Dark Leafy Green InterventionCruciferous and Dark Leafy Green InterventionParticipants receive individual dietary counseling from a Registered Dietitian who will focus on increasing intake of cruciferous and green leafy vegetables while addressing any disease- and treatment-related eating difficulties experienced by the participant.
Primary Outcome Measures
NameTimeMethod
Attrition ratesThroughout 12 week study period

Feasibility measure

Adverse events with reporting according to institutional review board policyThroughout 12 week study period
QuestionnaireAt conclusion of 12 week study period

Intervention preferences

Number of patients excluded or not agreeing to participateBaseline

Feasibility measure

Adherence to study protocol activities (research records and diet intake self-report)Throughout 12 week study period

Feasibility measure (e.g., percent of assessments completed, percent of counseling phone calls completed, servings of cruciferous vegetables eaten, etc.)

Secondary Outcome Measures
NameTimeMethod
Quality of life (assessed using the Functional Assessment of Cancer Therapy Head and Neck index)At beginning and end of 12 week study period
DNA methylationAt beginning and end of 12 week study period
CovariatesAt beginning of 12 week study period

A questionnaire will collect a set of covariates used in the analyses (i.e., these do not represent individual outcomes; this is a group of covariates used in the data analyses). This group includes demographic characteristics (age, sex, race, ethnicity, education, income); lifestyle behaviors (tobacco use, alcohol consumption, exercise); medical history; cancer-specific clinical variables (tumor site, cancer stage, treatment modality); anthropometrics (height and weight)

Serum cytokinesAt beginning and end of 12 week study period
Total energy and nutrient intakesAt beginning and end of 12 week study period
© Copyright 2025. All Rights Reserved by MedPath